Lori Anne Kunkel - 03 Mar 2025 Form 4 Insider Report for Oric Pharmaceuticals, Inc. (ORIC)

Role
Director
Signature
/s/ Christian Kuhlen, attorney-in-fact
Issuer symbol
ORIC
Transactions as of
03 Mar 2025
Net transactions value
+$233,512
Form type
4
Filing time
04 Mar 2025, 17:27:04 UTC
Previous filing
10 Feb 2025
Next filing
19 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORIC Common Stock Options Exercise $103,748 +27,666 +135% $3.75 48,166 03 Mar 2025 Direct
transaction ORIC Common Stock Options Exercise $129,765 +20,500 +43% $6.33 68,666 03 Mar 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORIC Stock Option (right to buy) Options Exercise $0 -27,666 -83% $0.000000 5,534 03 Mar 2025 Common Stock 27,666 $3.75 Direct F1
transaction ORIC Stock Option (right to buy) Options Exercise $0 -20,500 -100% $0.000000 0 03 Mar 2025 Common Stock 20,500 $6.33 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 (A) 20,500 of the shares subject to the option shall vest on the earlier of (i) June 17, 2023 or (ii) the business day prior to the next annual meeting of the Issuer's stockholders that occurs following the date of grant, and (B) one thirty-sixth (1/36th) of the remaining 33,200 shares subject to the option shall vest on each monthly anniversary of June 17, 2022.